Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex is the core molecular machinery required for membrane fusion and neurotransmitter release in the nervous system (Südhof, 2013, Neuron). It is primarily composed of three proteins: Syntaxin-1 and Synaptosome-associated protein 25 (SNAP-25), which are located on the presynaptic plasma membrane, and Vesicle-associated membrane protein 2 (VAMP-2), located on the synaptic vesicle (Jahn & Scheller, 2006, Nature Reviews Molecular Cell Biology). These proteins zip together to form a stable four-helix bundle that pulls the vesicle and plasma membranes into close proximity, facilitating their fusion and the subsequent release of neurotransmitters into the synaptic cleft. Mutations in these components are associated with a group of neurological disorders known as SNAREopathies, which include epilepsy and intellectual disabilities (Verhage & Sorensen, 2020, Neuron). Pharmacologically, the SNARE complex is the specific target of clostridial neurotoxins, such as Botulinum toxin and Tetanus toxin, which act as endopeptidases to cleave individual SNARE proteins (Pirazzini et al., 2017, Pharmacological Reviews). By disrupting the complex, these toxins inhibit exocytosis and block neuronal signaling, a property exploited therapeutically to treat conditions characterized by muscle overactivity or glandular hypersecretion. Common clinical applications include the treatment of cervical dystonia, spasticity, chronic migraine, and cosmetic enhancement (Nigam & Nigam, 2010, Indian Journal of Dermatology). Ongoing research also explores the role of SNARE proteins in psychiatric conditions like schizophrenia and their potential as biomarkers for synaptic integrity.
The mechanism of action involves the zinc-dependent proteolytic cleavage of specific SNARE proteins by clostridial neurotoxins. Botulinum neurotoxins (BoNT) and Tetanus toxin (TeNT) enter neurons and their light chains cleave SNAP-25, VAMP, or Syntaxin-1. This cleavage prevents the assembly of the SNARE complex, which is essential for the fusion of synaptic vesicles with the presynaptic membrane, thereby blocking the release of neurotransmitters like acetylcholine (Pirazzini et al., 2017, Pharmacological Reviews).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Syntaxin-1 and Soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex components (SNARE complex) (SNARE complex).